Three peroxidovanadium(v) compounds mediated by transition metal cations for enhanced anticancer activity

Area of Science:

• Inorganic Chemistry
• Medicinal Chemistry
• Cancer Biology

Background:

• Peroxidovanadium(V) compounds are explored for therapeutic potential.
• Ligand modification influences the properties of vanadium complexes.
• Transition metal cations can modulate the biological activity of metal complexes.

Purpose of the Study:

• To synthesize and characterize novel peroxidovanadium(V) compounds with varying ligands.
• To investigate the anticancer activities of these compounds, focusing on their interaction with transition metal cations.
• To elucidate the mechanisms underlying their selective cytotoxicity towards cancer cells.

Main Methods:

• Synthesis and characterization of three peroxidovanadium(V) compounds (L1-L3).
• In vitro cytotoxicity assays on cancer cell lines (MCF-7, A549) and normal cells (BEAS-2B).
• Evaluation of compound activity mediated by transition metal cations (Mn2+, Fe2+).
• Mechanistic studies including apoptosis induction, cell cycle analysis, and reactive oxygen species (ROS) generation.

Main Results:

• All synthesized peroxidovanadium(V) compounds exhibited enhanced cytotoxicity against cancer cells compared to normal cells.
• Manganese(II) (Mn2+) mediation significantly boosted the anticancer efficacy.
• The compounds induced cancer cell death via early apoptosis, cell cycle inhibition, and increased intracellular ROS production.
• An acidic environment and transition metal cations were crucial for the observed anticancer effects.

Conclusions:

• Transition metal cation-mediated peroxidovanadium(V) compounds demonstrate promising selective anticancer activity.
• The mechanism involves apoptosis induction, cell cycle arrest, and ROS generation.
• These findings provide valuable insights for developing vanadium-based anticancer agents for clinical applications.